Stryker EBIT Margin 2010-2023 | SYK
Stryker EBIT Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBIT | EBIT Margin |
2023-12-31 | $20.50B | $3.89B | 18.97% |
2023-09-30 | $19.89B | $3.45B | 17.32% |
2023-06-30 | $19.46B | $3.32B | 17.08% |
2023-03-31 | $18.95B | $3.13B | 16.51% |
2022-12-31 | $18.45B | $2.84B | 15.40% |
2022-09-30 | $17.95B | $2.85B | 15.86% |
2022-06-30 | $17.63B | $2.61B | 14.82% |
2022-03-31 | $17.43B | $2.57B | 14.76% |
2021-12-31 | $17.11B | $2.58B | 15.10% |
2021-09-30 | $16.67B | $2.51B | 15.08% |
2021-06-30 | $16.25B | $2.80B | 17.23% |
2021-03-31 | $14.72B | $2.05B | 13.91% |
2020-12-31 | $14.35B | $2.22B | 15.49% |
2020-09-30 | $14.22B | $2.42B | 17.00% |
2020-06-30 | $14.07B | $2.19B | 15.54% |
2020-03-31 | $14.96B | $2.82B | 18.86% |
2019-12-31 | $14.88B | $2.71B | 18.23% |
2019-09-30 | $14.55B | $2.47B | 16.96% |
2019-06-30 | $14.20B | $2.42B | 17.00% |
2019-03-31 | $13.88B | $2.47B | 17.83% |
2018-12-31 | $13.60B | $2.54B | 18.65% |
2018-09-30 | $13.28B | $2.55B | 19.23% |
2018-06-30 | $13.04B | $2.50B | 19.19% |
2018-03-31 | $12.73B | $2.33B | 18.32% |
2017-12-31 | $12.44B | $2.30B | 18.46% |
2017-09-30 | $12.13B | $2.25B | 18.57% |
2017-06-30 | $11.96B | $2.21B | 18.52% |
2017-03-31 | $11.79B | $2.21B | 18.77% |
2016-12-31 | $11.33B | $2.18B | 19.21% |
2016-09-30 | $10.88B | $2.15B | 19.78% |
2016-06-30 | $10.47B | $2.05B | 19.53% |
2016-03-31 | $10.06B | $1.97B | 19.62% |
2015-12-31 | $9.95B | $1.86B | 18.71% |
2015-09-30 | $9.85B | $1.68B | 17.07% |
2015-06-30 | $9.82B | $1.75B | 17.85% |
2015-03-31 | $9.75B | $1.52B | 15.60% |
2014-12-31 | $9.68B | $1.25B | 12.88% |
2014-09-30 | $9.53B | $1.21B | 12.68% |
2014-06-30 | $9.29B | $0.91B | 9.78% |
2014-03-31 | $9.14B | $1.00B | 10.96% |
2013-12-31 | $9.02B | $1.26B | 13.92% |
2013-09-30 | $8.89B | $1.20B | 13.45% |
2013-06-30 | $8.79B | $1.50B | 17.02% |
2013-03-31 | $8.69B | $1.65B | 19.01% |
2012-12-31 | $8.66B | $1.74B | 20.11% |
2012-09-30 | $8.53B | $1.79B | 20.96% |
2012-06-30 | $8.51B | $1.78B | 20.94% |
2012-03-31 | $8.45B | $1.74B | 20.57% |
2011-12-31 | $8.31B | $1.69B | 20.30% |
2011-09-30 | $8.09B | $1.65B | 20.45% |
2011-06-30 | $7.82B | $1.68B | 21.49% |
2011-03-31 | $7.54B | $1.73B | 22.93% |
2010-12-31 | $7.32B | $1.75B | 23.92% |
2010-09-30 | $7.16B | $1.88B | 26.25% |
2010-06-30 | $7.04B | $1.72B | 24.40% |
2010-03-31 | $6.92B | $1.66B | 24.00% |
2009-12-31 | $6.72B | $1.59B | 23.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $136.478B | $20.498B |
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
Perrigo (PRGO) | Ireland | $4.263B | 12.19 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |